Status of TMPRSS2–ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism

BACKGROUND: Prostate cancer (PCa) shows considerable clinical heterogeneity that has been primarily attributed to variable molecular alterations. TMPRSS2–ERG fusion is one such molecular subtype that has been associated with predominantly poor prognosis. More recently, a single nucleotide polymorphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhanushali, Aparna, Rao, Pranesh, Raman, Vaishnavi, Kokate, Prajakta, Ambekar, Asawari, Mandva, Swarna, Bhatia, Simi, Das, B.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251948/
https://www.ncbi.nlm.nih.gov/pubmed/30505817
http://dx.doi.org/10.1016/j.prnil.2018.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251948/
https://www.ncbi.nlm.nih.gov/pubmed/30505817
http://dx.doi.org/10.1016/j.prnil.2018.03.004

Ejemplares similares